EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Urinary protein vs albumin for assessing kidney failure risk in chronic kidney disease

Tadashi Toyama iD, Takahiro Imaizumi, Takayuki Hamano iD, Hirotaka Komaba, Naohiko Fujii, Takeshi Hasegawa iD, Masahiko Ando, Masaomi Nangaku iD, Kosaku Nitta, Yoshitaka Isaka iD, Takashi Wada, Shoichi Maruyama iD und 1 weitere

Nephrology Dialysis Transplantation · 29.06.2026

DOI: 10.1093/ndt/gfag122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 29.06.2026. Verfasst von Tadashi Toyama und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Faculty of Medical Sciences, University of Fukui, Yoshida-gun, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CKD, JAC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and hypothesis The urinary albumin-to-creatinine ratio (UACR) is an established surrogate endpoint for kidney failure in chronic kidney disease (CKD). However, proteinuria remains widely used in routine clinical practice in several countries due to its accessibility and cost-effectiveness. Moreover, the comparative utility of UACR and proteinuria as surrogate endpoints is not well-defined.

Methods

We analyzed data from the Chronic Kidney Disease Japan Cohort to examine the association between a 30% decrease in urinary protein-to-creatinine ratio (UPCR) or UACR over 2 years and the subsequent risk of kidney failure requiring replacement therapy (KFRT). We also examined the relationship between a 30% decrease in UPCR over 1 year and the risk of KFRT. Associations were evaluated using multivariable Cox proportional hazards models.

Results

Among the 2966 patients, 603 had both UACR and UPCR data available over 2 years. Their mean age was 60 years, mean estimated glomerular filtration rate (eGFR) was 29 ml/min/1.73 m², median UPCR was 0.81 g/gCr, and median UACR was 601 mg/gCr. During a median follow-up of 4.9 years, 245 patients (40.6%) progressed to KFRT. A 30% decrease in UPCR over 2 years was significantly associated with a lower risk of KFRT [hazard ratio (HR), 0.52 (0.38, 0.71)], with comparable findings for UACR [HR, 0.58 (0.41, 0.82)]. A similar association was observed for UPCR over 1 year among 831 patients [HR 0.56 (0.43, 0.73)]. Subgroup analyses showed consistent associations across most baseline characteristics. Nevertheless, the association of UPCR change was weaker than that of UACR change in patients with eGFR < 15 ml/min/1.73 m², possibly reflecting the reduced urinary albumin-to-protein ratio.

Conclusions

In patients with CKD, a 30% decrease in UPCR or UACR over 2 years may serve as a comparable surrogate endpoint for subsequent KFRT. Nonetheless, caution is warranted in patients with eGFR < 15 ml/min/1.73 m².

Schlagwörter

Stichwörter der Autor:innen

albuminuriachronic renal insufficiencycohort studykidney failureproteinuriasurrogate endpoint

Autor:innen und Institutionen

  • Department of Nephrology, Faculty of Medical Sciences, University of Fukui, Yoshida-gun, Japan.
  • Department of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
  • Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Nephrology, Nagoya City University Graduate School of Medicine, Nagoya, Japan.
  • Department of Nephrology, The University of Osaka Graduate School of Medicine, Suita, Japan.

ORCID-Profile: Tadashi Toyama, Takayuki Hamano, Takeshi Hasegawa, Masaomi Nangaku, Yoshitaka Isaka, Shoichi Maruyama, Masafumi Fukagawa

Förderung

  • CKD
  • JAC

Zitieren

APA

Toyama, T., Imaizumi, T., Hamano, T., Komaba, H., Fujii, N., Hasegawa, T., Ando, M., Nangaku, M., Nitta, K., Isaka, Y., Wada, T., Maruyama, S., & Fukagawa, M. (2026). Urinary protein vs albumin for assessing kidney failure risk in chronic kidney disease. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfag122

Vancouver

Toyama T, Imaizumi T, Hamano T, Komaba H, Fujii N, Hasegawa T, et al. Urinary protein vs albumin for assessing kidney failure risk in chronic kidney disease. Nephrology Dialysis Transplantation. 2026. doi:10.1093/ndt/gfag122

BibTeX
@article{Toyama2026,
  author = {Toyama, Tadashi and Imaizumi, Takahiro and Hamano, Takayuki and Komaba, Hirotaka and Fujii, Naohiko and Hasegawa, Takeshi and Ando, Masahiko and Nangaku, Masaomi and Nitta, Kosaku and Isaka, Yoshitaka and Wada, Takashi and Maruyama, Shoichi and Fukagawa, Masafumi},
  title = {Urinary protein vs albumin for assessing kidney failure risk in chronic kidney disease},
  journal = {Nephrology Dialysis Transplantation},
  year = {2026},
  doi = {10.1093/ndt/gfag122}
}
Kostenlos starten →